By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported a 13 percent spike in third-quarter revenues, but reduced its earnings guidance for full-year 2011.

For the three months ended Oct. 1, the company saw revenues climb to $454.5 million, up from $401 million a year ago, driven by new instrument systems, including the Acquity H-Class UPLC, UPLC-mass spectrometer solutions, as well as strong TA Instruments product shipments, Douglas Berthiaume, president and CEO of Waters, said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.